Date: 2014-09-30
Type of information: Construction of new premises
Compound: R&D facility
Company: Jacobs Engineering Group (USA - CA) Novo Nordisk (Denmark)
Therapeutic area:
Type agreement: construction of new premises services contract
Action mechanism:
Disease:
Details: * On September 29, 2014, Jacobs Engineering Group announced that it has been awarded a contract from Novo Nordisk for a research and development facility in Bagsværd, Denmark. Under the terms of the contract, Jacobs is providing engineering, procurement and construction management services for a new purification pilot plant project, which initially involves one purification line. The project is expected to expand Novo Nordisk’s capacity to produce active pharmaceutical ingredients for a growing number of diabetes drugs in development. The pilot plant is expected to be fully operational by late 2016. The facility has the potential to be expanded twofold in the future to provide further production capacity.
Financial terms: Officials did not disclose the contract value.
Latest news:
